Drug & intervention
alogliptin 25 MG / pioglitazone 45 MG Oral Tablet [Oseni]
RxCUI 1368444
What this record represents
SBD · RxNormThis is an RxNorm SBD drug concept. Its name, formulation details and source identifiers are preserved to distinguish it from other drug records.
What this record does not establish: current marketing availability, therapeutic equivalence, safety, or official approval status. Check an up-to-date product label or a pharmacist for product-specific questions.
Related drug records
RxNorm name matchesThese are other published drug concepts with matching brand or formulation names. They are not necessarily equivalent medicines.
OseniBN · CureCurrent ID 55737
alogliptin / pioglitazone Oral Tablet [Oseni]SBDF · CureCurrent ID 55441
alogliptin 25 MG / pioglitazone 15 MG [Oseni]SBDC · CureCurrent ID 55437
alogliptin 25 MG / pioglitazone 30 MG [Oseni]SBDC · CureCurrent ID 55440
alogliptin 25 MG / pioglitazone 45 MG [Oseni]SBDC · CureCurrent ID 55444
alogliptin 12.5 MG / pioglitazone 30 MG [Oseni]SBDC · CureCurrent ID 55433
alogliptin 25 MG / pioglitazone 15 MG Oral Tablet [Oseni]SBD · CureCurrent ID 55438
alogliptin 25 MG / pioglitazone 30 MG Oral Tablet [Oseni]SBD · CureCurrent ID 55442
alogliptin 12.5 MG / pioglitazone 30 MG Oral Tablet [Oseni]SBD · CureCurrent ID 55434
Advertisement
Active ingredients and chemical structures
RxNorm ingredient relationships. Structures are retrieved by PubChem compound identifier when available. An ingredient can have both a base and a precise salt concept.
Conditions being studied
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.